VSWA
RDY icon

Vontobel Swiss Wealth Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Vontobel Swiss Wealth Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,000
Closed -$10K – 92
2014
Q4 		$10K Buy
+1,000
New +$10.5K 0.01% 106

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Group
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Causeway Capital Management
Causeway Capital Management Los Angeles, California $9.24B AUM 21.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vontobel Swiss Wealth Advisors's RDY Position: Q1 2015 in Review

Vontobel Swiss Wealth Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q1 2015, closing a stake of 1,000 shares — an estimated $10K sold.

Vontobel Swiss Wealth Advisors first reported a position in RDY in Q4 2014 and held it in 1 quarter. The position peaked at $10K in Q4 2014. 174 funds tracked by Wall St. Rank hold RDY as of Q1 2015.

  • Vontobel Swiss Wealth Advisors reported no remaining Dr. Reddy's Laboratories position as of Q1 2015 after selling out during the quarter.
  • Vontobel Swiss Wealth Advisors sold 1,000 Dr. Reddy's Laboratories shares in Q1 2015, an estimated $10K.
  • Vontobel Swiss Wealth Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2014 and held it in 1 quarter.
  • Vontobel Swiss Wealth Advisors's Dr. Reddy's Laboratories position peaked at $10K in Q4 2014.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2015.

Based on Vontobel Swiss Wealth Advisors's 13F filing for Q1 2015, filed 13 May 2015.